CVS Health Corporation (CVS) Is A Key Part Of Weight Loss Drug Distribution, Says Jim Cramer

We recently published 10 Stocks That Jim Cramer Talked About. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently discussed.

CVS Health Corporation (NYSE:CVS) is one of the largest pharmaceutical retailers in America. The shares have gained 36% year-to-date as the firm has enjoyed tailwinds from the struggles of its rival Walgreens. CVS Health Corporation (NYSE:CVS) has also benefited from robust earnings performance and the decision to exit its Obamacare direct sales business. Cramer’s previous comments have praised CVS Health Corporation (NYSE:CVS)’s performance in its core drug store business. This time, he pointed to the role the firm plays in the weight loss drug market:

“[If market should start thinking about sectoral tariffs after Trump’s latest remarks]I mean when I heard it first I said okay, so they put a tariff on Novo Nordisk. It’s really good for Eli Lilly. Now that’s not necessarily what we’re talking about but remember this price differential right now. . CVS, Eli Lilly versus Novo. So for Wegovy versus Zepbound.”

In an earlier appearance, Cramer discussed CVS Health Corporation (NYSE:CVS)’s business performance:

“Now we’ve got some healthcare, some issues to talk about on Thursday, that’s right, and these are anything but common steady healthcare companies…. There’s CVS, which is under new management, put up some really good numbers, and it’s just, that’s in health insurance, but also it’s core drugstore business, which they’ve closed, all the under performers… As for CVS, the health insurers have taken it on the chin of late. UnitedHealth and Centene both missed expectations. I bet Aetna sticks it.”

While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.